Erste Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $3.08M | Hold |
|
|||||
|
2024
Q4 | $1.99M | Hold |
|
|||||
|
2024
Q3 | $1.72M | Hold |
|
|||||
|
2024
Q2 | $1.66M | Hold |
|
|||||
|
2024
Q1 | $1.63M | Hold |
|
|||||
|
2023
Q4 | $1.68M | Hold |
|
|||||
|
2023
Q3 | $1.26M | Hold |
|
|||||
|
2023
Q2 | $1.45M | Hold |
|
|||||
|
2023
Q1 | $1.31M | Hold |
|
|||||
|
2022
Q4 | $1.25M | Hold |
|
|||||
|
2022
Q3 | $1.06M | Hold |
|
|||||
|
2022
Q2 | $1.36M | Hold |
|
|||||
|
2022
Q1 | $1.41M | Buy |
|
|||||
|
2021
Q4 | $1.09M | Hold |
|
|||||
|
2021
Q3 | $752K | Hold |
|
|||||
|
2021
Q2 | $835K | Hold |
|
|||||
|
2021
Q1 | $683K | Hold |
|
|||||
|
2020
Q4 | $655K | Hold |
|
|||||
|
2020
Q3 | $536K | Buy |
|